Explained: A brief look into AlphaFold 2
The year 2021 has been a wild ride for structural biologists, with the advent of AlphaFold2,...
BioStrand Omics Analysis Blog:
AI (2)
AI-powered genomics to advance precision medicine
Sir William Osler, often called the father of modern medicine, was among the first to articulate a ...
AI, NLP and the ROI of drug development
The out-of-pocket R&D costs of developing a single drug, whether successfully launched or not, are...
Accelerating pharma R&D and innovation through technology partnerships
Biopharmas are increasingly turning to alliances & partnerships to drive external innovation....
Computational Antibody Design: The Future Of Antibody Discovery
In 2021, the FDA approved the 100th monoclonal antibody product, marking a significant milestone...
Improving Drug Safety with Adverse Event Detection Using NLP
It is estimated that Adverse Events (AEs) are likely one of the 10 leading causes of death and...
A Hybrid Approach to NLP in Drug Discovery
Artificial Intelligence-powered technologies like NLP are becoming critical to the pharmaceutical...
AI in early phase drug development
AI technologies are currently the most disruptive trend in the pharmaceutical industry. Over the...
Efficient data integration is the key to effective AI/ML
AI/ML technologies can be notoriously data-hungry with the broader concern being that certain...
Knowledge Graphs & The Power Of Context
Data overload is becoming a real challenge for businesses of all stripes even as a majority...
AI, ML, DL, and NLP: An Overview
Today artificial intelligence (AI), machine learning (ML), deep learning (DL) and natural language...